Summary
This study was designed to develop an animal model of Type 2 (non-insulin-dependent) diabetes with persistent hypertension. Male spontaneously hypertensive rats were treated with 25.0, 37.5, 50.0, 62.5 or 75.0 mg/kg of streptozotocin given intraperitoneally at 2 days of age and maintained for 12 weeks. In the rats which received 50.0 mg/kg or more streptozotocin, overt hyperglycaemia gradually and consistently developed following incomplete recovery from an initial hyperglycaemia. Compared to vehicle-treated controls, body weight gain in these animals did not differ for the first 8 weeks; thereafter, it was slightly but significantly (p < 0.05) reduced. The animals treated with 25.0 or 37.5 mg/kg streptozotocin developed mild to moderate hyperglycaemia, but their body weight gain was similar to controls. The relationships between streptozotocin dose and metabolic responses (plasma glucose, glycosylated haemoglobin, urinary glucose, food intake, etc.) were clearly demonstrated. Systolic blood pressure rose with progressing age in both controls and streptozotocin-treated rats, irrespective of dosage or metabolic response. This new rat model of Type 2 diabetes associated with persistent hypertension may be useful in studying these combined effects on small and large vessels.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Drury PL (1983) Diabetes and arterial hypertension. Diabetologia 24:1–9
Koletsky S (1973) Obese spontaneously hypertensive rats — a model for study of atherosclerosis. Exp mol Path 19: 53–60
Mauer SM, Steffes MW, Azar S, Sanderg SK, Brown DM (1978) The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 27: 738–744
Factor SM, Bhan R, Minase T, Wolinsky H, Sonnenblick EH (1981) Hypertensive-diabetic cardiomyopathy in the rat. An experimental model of human disease. Am J Pathol 102: 219–228
Portha B, Picon L, Rosselin G (1979) Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17: 371–377
Bonner-Weir S, Trent DF, Honey RN, Weir GC (1981) Responses of neonatal rat islets to streptozotocin. Limited B-cell regeneration and hyperglycemia. Diabetes 30: 64–69
Wexler BC, Iams SG, McMurtry JP (1980) Pathophysiological differences between obese and non-obese spontaneously hypertensive rats. Br J Exp Path 61: 195–207
Hashimoto Y (1969) Effect of alloxan diabetes induced in spontaneously hypertensive rats. Jap Circul J 33: 1315–1338
Iams SG, Wexler BC (1977) Alloxan diabetes in spontaneously hypertensive rats: gravimetric, metabolic and histopathological alterations. Br J Exp Path 58: 177–199
Somani P, Singh HP, Saini RK, Rabinovitch A (1979) Streptozotocin-induced diabetes in the spontaneously hypertensive rat. Metabolism 28:1075–1077
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwase, M., Kikuchi, M., Nunoi, K. et al. A new model of Type 2 (non-insulin-dependent) diabetes mellitus in spontaneously hypertensive rats: diabetes induced by neonatal streptozotocin treatment. Diabetologia 29, 808–811 (1986). https://doi.org/10.1007/BF00873221
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00873221